Since 1982, blood-pressure-lowering ACE inhibitor medications like Accupril and Lotensin have been helpful in treating many conditions, particularly those related to cardiovascular disease….
For decades, warfarin (brand name Coumadin) was the leading choice of physicians for patients who required a blood-thinning drug, such as those with atrial fibrillation who were at a higher risk…
We know that antidepressants like Paxil, Zoloft and Prozac can increase risk of suicidal thoughts and behaviors in young people, and may increase risk for birth defects when taken in pregnant…
According to a recent report, stores are short of Tylenol. Go down to your local Walgreen's or Rite Aid and you may have trouble finding it. The report details the numerous recalls that…
Approved in 2007 for use as a treatment for high blood pressure, Tekturna (aliskiren) has recently come under scrutiny because of reports of serious Tekturna side effects. In December 2011,…
There's a long list of dietary supplements seeking attention in the fitness industry, from energy enhancers to fat burners to pre-workout boosters. Some, however, contain more than vitamins,…
Women who took selective serotonin reuptake inhibitor (SSRI) antidepressants during their pregnancies and then gave birth to children with birth defects are seeking damages in court. Hundreds…
If you're a woman and you're pregnant, likely you're no stranger to heartburn. Increased levels of certain hormones, as well as pressure from the expanding uterus, can cause stomach…
Many patients who used Actos and developed bladder cancer didn't realize until June 2011 that their diabetes medication might be to blame. That was the month the FDA released a safety…
The first Yaz bellwether trial in the Illinois MDL was scheduled to take place in January 2012, but that didn't happen. Chief Judge David R. Herndon of the U.S. District Court for the…
The long-term safety of bone-building drugs like Fosamax has been of particular concern over the last couple of years. A recent analysis published by the FDA adds additional support to the…
On June 15, 2011, the FDA released a safety announcement warning the public and healthcare professionals that long-term use of the diabetes drug Actos may increase the risk of bladder cancer. The…